Počet záznamov: 1
rosiglitazón
SYS d000077154 LBL 00000nz--a2200181n--4500 005 20250606222637.3 008 190101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 $d BA006 065 $a D02.886.675.933.500 065 $a D03.383.129.708.933.500 066 $a 01 $c 03 150 $a rosiglitazón $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a Avandia $2 slo 450 $w v $a rosiglitazón maleát $2 slo 550 $7 sllk_us_auth*d007004 $Y Hypoglycemic Agents $w P $a hypoglykemiká 550 $7 sllk_us_auth*d000077205 $Y Pioglitazone $w p $a pioglitazón 550 $7 sllk_us_auth*d000077205 $Y Pioglitazone $w b $a pioglitazón 665 $a 2019 (1994) $2 eng 680 9-
$i A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS. $2 eng 750 -2
$a Rosiglitazone $2 eng 980 $x M
Počet záznamov: 1